Cited 1 times in
Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.